Stay updated on Nivolumab for Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab for Esophageal Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, a minor version update visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Locations section shows new recruitment sites across multiple regions and removal of some prior sites. Revision updated to v3.3.3.SummaryDifference2%

- Check50 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 removed, indicating a site version update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedPublication notes were clarified to indicate that publications are automatically filled from PubMed and may not be about the study. The revision information was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded location 'Tainan, Taiwan, 704' and removed 'Tainan City, Taiwan, 704' from the study locations.SummaryDifference0.2%

- Check79 days agoChange DetectedThe page shows minor layout and timestamp updates. Core study data such as eligibility criteria, primary outcomes, and enrollment remain unchanged.SummaryDifference0.3%

Stay in the know with updates to Nivolumab for Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.